Ilumya 47335-0177
Generic: Tildrakizumab-Asmn
Product NDC
47335-0177- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 6, 2018
- Listing Expires
- December 31, 2026
- Application
- BLA761067
Need to source Ilumya? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tildrakizumab | 100 mg/mL |
Drug Class
Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-23 Antagonists [MoA]
Packaging Options(4)
1 mL in 1 SYRINGE, GLASS (47335-177-01)
1 mL in 1 CARTON (47335-177-10)
1 mL in 1 CARTON (47335-177-95)
1 mL in 1 SYRINGE, GLASS (47335-177-96)